ATE220105T1 - Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung - Google Patents

Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung

Info

Publication number
ATE220105T1
ATE220105T1 AT92910129T AT92910129T ATE220105T1 AT E220105 T1 ATE220105 T1 AT E220105T1 AT 92910129 T AT92910129 T AT 92910129T AT 92910129 T AT92910129 T AT 92910129T AT E220105 T1 ATE220105 T1 AT E220105T1
Authority
AT
Austria
Prior art keywords
pichia
proteolytic activity
genes
genes affecting
strains
Prior art date
Application number
AT92910129T
Other languages
English (en)
Inventor
Martin Anthony Gleeson
Bradley Drake Howard
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24724845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE220105(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE220105T1 publication Critical patent/ATE220105T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/938Pichia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92910129T 1991-04-01 1992-03-31 Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung ATE220105T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67891691A 1991-04-01 1991-04-01
PCT/US1992/002521 WO1992017595A1 (en) 1991-04-01 1992-03-31 Genes which influence pichia proteolytic activity, and uses therefor

Publications (1)

Publication Number Publication Date
ATE220105T1 true ATE220105T1 (de) 2002-07-15

Family

ID=24724845

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910129T ATE220105T1 (de) 1991-04-01 1992-03-31 Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung

Country Status (9)

Country Link
US (5) US5324660A (de)
EP (1) EP0578746B1 (de)
JP (2) JPH06506117A (de)
AT (1) ATE220105T1 (de)
AU (1) AU661844B2 (de)
CA (1) CA2105064A1 (de)
DE (1) DE69232666T2 (de)
ES (1) ES2177528T3 (de)
WO (1) WO1992017595A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
ATE220105T1 (de) * 1991-04-01 2002-07-15 Merck & Co Inc Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung
FR2692907B1 (fr) * 1992-06-25 1995-06-30 Rhone Poulenc Rorer Sa Levures kluyveromyces modifiees, preparation et utilisation.
US5674728A (en) * 1993-11-03 1997-10-07 Novartis Corporation Aspergillus niger vacuolar aspartyl protease
ATE256191T1 (de) * 1994-06-17 2003-12-15 Novozymes As Ein pilz, in dem das area-gen verändert ist, und ein area-gen aus aspergillus oryzae
US5594119A (en) * 1994-09-20 1997-01-14 Novo Nordisk A/S Gene encoding carboxypeptidase of aspergillus niger
JP3974171B2 (ja) * 1995-03-20 2007-09-12 ノボザイムス アクティーゼルスカブ 低下したレベルのメタロプロテアーゼを発見する宿主細胞及びその細胞をタンパク質の生産に用いる方法
EP0852625A2 (de) * 1995-09-25 1998-07-15 Chiron Corporation Sekretorische 'leader'-sequenz aus pichia zur protein-expression
US6153424A (en) * 1995-11-09 2000-11-28 Zymogenetics, Inc. Protease-deficient strains of Pichia methanolica
AU1092897A (en) * 1995-12-15 1997-07-14 Novo Nordisk A/S A funguns wherein the area, pepc and/or pepe genes have been inactivated
JP4263241B2 (ja) * 1996-03-27 2009-05-13 ノボザイムス アクティーゼルスカブ アルカリプロテアーゼを欠失した糸状真菌
US6110703A (en) * 1996-07-05 2000-08-29 Novo Nordisk A/S Method for the production of polypeptides
EP0956338B1 (de) * 1996-09-19 2005-12-21 Novozymes A/S Wirtszellen und methoden für die produktion von proteinen
JP2001512684A (ja) 1997-08-05 2001-08-28 カイロン コーポレイション 新規のpichiapastoris遺伝子配列およびそれらの使用方法
CA2303408C (en) * 1997-09-15 2005-05-03 Zymogenetics, Inc. Chromosomal mutagenesis in pichia methanolica
US6183953B1 (en) 1997-09-15 2001-02-06 Zymogenetics, Inc. Chromosomal mutagenesis in Pichia methanolica
AU9231898A (en) * 1997-09-15 1999-04-05 Zymogenetics Inc. Protease-deficient strains of (pichia methanolica)
US6605450B1 (en) 2000-05-25 2003-08-12 Chiron Corporation Iron regulation of the PpSEC10 transcriptional regulatory region of Pichia pastoris and methods of use
US20060034828A1 (en) * 2000-06-28 2006-02-16 Gerngross Tillman U Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
US20060257399A1 (en) * 2000-06-28 2006-11-16 Glycofi, Inc. Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform
US20060029604A1 (en) * 2000-06-28 2006-02-09 Gerngross Tillman U Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
US20060034830A1 (en) * 2000-06-28 2006-02-16 Gerngross Tillman U Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
WO2002101038A1 (fr) 2001-05-29 2002-12-19 Asahi Glass Company, Limited Procede de construction d'un hote et procede de production d'une proteine etrangere
US20060034829A1 (en) * 2001-12-27 2006-02-16 Gerngross Tillman U Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
US20060024292A1 (en) * 2001-12-27 2006-02-02 Gerngross Tillman U Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
US7972809B2 (en) 2002-04-26 2011-07-05 National Institute Of Advanced Industrial Science & Technology Methylotrophic yeast producing mammalian type sugar chain
US7514253B2 (en) 2003-05-16 2009-04-07 Glycofi, Inc. URA5 gene and methods for stable genetic integration in yeast
CA2541651C (en) 2003-10-22 2011-05-24 Keck Graduate Institute Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
WO2005123915A1 (en) * 2004-06-21 2005-12-29 Novozymes A/S Stably maintained multiple copies of at least two orf in the same orientation
CA2531616A1 (en) * 2004-12-28 2006-06-28 Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel, Ltd.) High strength thin steel sheet having high hydrogen embrittlement resisting property and high workability
EP1937305A4 (de) * 2005-09-09 2008-10-08 Glycofi Inc Immunglobulin, das vorwiegend eine man7glcnac2, man8glcnac2 glycoform enthält
WO2010099195A1 (en) * 2009-02-26 2010-09-02 Glaxosmithkline Llc. Host cells and methods of use
EP2494050A4 (de) * 2009-10-30 2013-10-30 Merck Sharp & Dohme In glycoengineerter pichia pastoris hergestellter granulozytenkolonienstimulierender faktor
US8703444B2 (en) 2009-12-14 2014-04-22 Centre Hospitalier Universitaire Vaudois (Chuv) Pichia pastoris deficient in endogenous secreted protease
US9096871B2 (en) 2010-10-06 2015-08-04 Bp Corporation North America Inc. Variant CBH I polypeptides with reduced product inhibition
JP7717459B2 (ja) 2018-02-12 2025-08-04 ロンザ リミテッド 目的タンパク質を産生するための宿主細胞
EP3884037A1 (de) * 2018-11-19 2021-09-29 Basf Se Rekombinante hefezelle
JP7061234B2 (ja) 2019-01-11 2022-04-27 ロンザ リミテッド 組換え宿主細胞内での炭素源調節タンパク質産生
WO2020200415A1 (en) 2019-04-01 2020-10-08 Lonza Ltd Mut- methylotrophic yeast
JP7570346B2 (ja) 2019-04-01 2024-10-21 ウニヴェルズィテート・フューア・ボーデンクルトゥーア・ウィーン Mut-メチロトローフ酵母
WO2020200414A1 (en) 2019-04-01 2020-10-08 Lonza Ltd Protein production in mut-methylotrophic yeast
ES3034258T3 (en) 2020-04-01 2025-08-14 Lonza Ag Helper factors for expressing proteins in yeast
CN116490517A (zh) 2020-09-30 2023-07-25 龙沙有限公司 过表达翻译因子的宿主细胞
WO2024133538A1 (en) 2022-12-20 2024-06-27 Lonza Ltd Host cells with pat1 knockout for increased specific protein productivity

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
NZ207842A (en) * 1983-04-25 1988-02-12 Chiron Corp Production of human insulin-like growth factor (igf) using cdna
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4870008A (en) * 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
US4839295A (en) * 1984-06-08 1989-06-13 Pierce Chemical Company Measurement of protein using bicinchoninic acid
CA1341130C (en) * 1984-07-27 2000-10-31 Adrianus Marinus Ledeboer Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
US4879231A (en) * 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4837148A (en) * 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US4885242A (en) * 1984-10-30 1989-12-05 Phillips Petroleum Company Genes from pichia histidine pathway and uses thereof
GB8521496D0 (en) * 1985-08-29 1985-10-02 Ciba Geigy Ag Repressible yeast promoters
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
US4812405A (en) * 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
GB2188933A (en) * 1986-04-10 1987-10-14 Bayer Ag Expression vectors for production of polypeptides, method for enhanced expression of polypeptides, hosts containing the expression vectors, products manufactured thereby
US5002876A (en) * 1986-09-22 1991-03-26 Phillips Petroleum Company Yeast production of human tumor necrosis factor
US4929555A (en) * 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
WO1989004320A1 (en) * 1987-11-02 1989-05-18 The Salk Institute Biotechnology/Industrial Associ PRODUCTION OF ANIMAL LYSOZYME c VIA SECRETION FROM PICHIA PASTORIS AND COMPOSITION THEREFOR
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
ES2204884T3 (es) * 1988-01-05 2004-05-01 Roche Diagnostics Gmbh Procedimiento para la obtencion de proteinas o productos genicos que contienen proteinas.
EP0336056B1 (de) * 1988-01-27 1995-04-05 M & D RESEARCH CO., LTD. Protease
AU614121B2 (en) * 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
WO1990000191A1 (en) * 1988-07-01 1990-01-11 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of rabies glycoprotein g and composition therefor
GB8819826D0 (en) * 1988-08-20 1988-09-21 Kabivitrum Ab Glycosylated igf-1
IL91512A0 (en) * 1988-09-09 1990-04-29 Salk Inst Biotech Ind Production of interluekin-2 poly-peptides in pichia pastoris yeast cells
IL91765A0 (en) * 1988-09-26 1990-06-10 Salk Inst Biotech Ind Mixed feed recombinant yeast fermentation
US5204252A (en) * 1989-02-08 1993-04-20 Henkel Research Corporation Candida tropicalis transformation system
AU5196290A (en) * 1989-02-13 1990-09-05 Salk Institute Biotechnology/Industrial Associates, Inc., The Production of superoxide dismutase in pichia pastoris yeast cells
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
US5122465A (en) * 1989-06-12 1992-06-16 Phillips Petroleum Company Strains of pichia pastoris created by interlocus recombination
US5231010A (en) * 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
WO1991005057A1 (en) * 1989-09-28 1991-04-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Cd4 production in pichia pastoris
US5258302A (en) * 1990-07-03 1993-11-02 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA for expression of aprotinin in methylotrophic yeast cells
EP0548267A4 (en) * 1990-09-04 1994-11-23 Salk Inst Biotech Ind Production of insulin-like growth factor-1 in methylotrophic yeast cells
JPH06503718A (ja) * 1990-09-05 1994-04-28 メルク エンド カンパニー インコーポレーテッド メチロトローフ酵母細胞におけるヒトリゾチムの産生とその効率的な分泌
JPH07108232B2 (ja) * 1990-10-09 1995-11-22 エム・ディ・リサーチ株式会社 ペプチド又は蛋白質の製造方法
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
WO1992013951A1 (en) * 1991-02-04 1992-08-20 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of human serum albumin in methylotrophic yeast cells
ATE220105T1 (de) * 1991-04-01 2002-07-15 Merck & Co Inc Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung
US5213010A (en) * 1991-05-07 1993-05-25 Toshiba Kikai Kabushiki Kaisha Driver power transmitting apparatus of twin shaft extruders
WO1993009233A2 (en) * 1991-10-31 1993-05-13 The Salk Institute Biotechnology/Industrial Associates Inc. Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states

Also Published As

Publication number Publication date
US5831053A (en) 1998-11-03
WO1992017595A1 (en) 1992-10-15
US5541112A (en) 1996-07-30
DE69232666T2 (de) 2003-03-20
US5691166A (en) 1997-11-25
AU661844B2 (en) 1995-08-10
AU1750592A (en) 1992-11-02
DE69232666D1 (de) 2002-08-08
ES2177528T3 (es) 2002-12-16
US6051419A (en) 2000-04-18
CA2105064A1 (en) 1992-10-02
JPH06506117A (ja) 1994-07-14
JP2003159090A (ja) 2003-06-03
EP0578746A1 (de) 1994-01-19
EP0578746B1 (de) 2002-07-03
US5324660A (en) 1994-06-28

Similar Documents

Publication Publication Date Title
ATE220105T1 (de) Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung
ATE294867T1 (de) Mutierte alpha-amylase aus bacillus licheniformis,die eine modifizierung von resten a210, h405 und/oder t412 enthält
ATE80657T1 (de) Mischungen von alpha-amylase zur verfluessigung von staerke.
ATE171474T1 (de) Hochstabile rekombinante hefen für die herstellung von rekombinanten proteinen
DE3486139D1 (de)
ATE110419T1 (de) Nachweis von listeria.
FI971953A0 (fi) Proteiinityrosiinikinaasin välittämää soluproliferaatiota inhiboivat 6-aryyli-pyrido(2,3-d)pyrimidiinit ja naftyridiinit
DE69329202D1 (de) Methoden der erhöhung der sekretion von überexpremierten proteinen
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
DE69333727D1 (de) Protein-C-Derivat
SE9703606L (sv) Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav
NO944448D0 (no) Nye farmasöytiske anvendelser av krill-enzymer
KR970009949B1 (en) Novel serine proteolytic enzyme and its process
KR880701728A (ko) 조직-형 및 우로키나제-형 플라스 미노겐 활성체 억제제의 진단검정 방법 및 억제제의 암호화 유전자
ATE156859T1 (de) Varianten von pai-2
FI853648A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva 4,5-dihydro-4-okso-2-/(2-trans-fenylcyklopropyl) amino/-3-furankarboxylsyror och derivat daerav.
AU3347293A (en) Expression signal-peptide-free staphylokinases
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
DK0713365T4 (da) Rugmel
ES2042988T3 (es) Acidos 1h-indazol-3-aceticos como inhibidores de aldosareductasa.
DE69728165D1 (de) Cycloalkyl inhibitoren der protein-farnesyltransferase
NO933153L (no) Fremgangsmåte for fremstilling av protease-inhibitorer
ES2037603A1 (es) Procedimiento para la obtencion de preparados de enzimas, sin agentes superficie activos, pulverulentos o granulados conteniendo proteasa como enzima activa.
ES423716A1 (es) Procedimiento para la obtencion de 1,4-dihidroquinolinas.
DE59408793D1 (de) Galenische Zubereitungen von Molsidomin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties